Subtopic Deep Dive
Corneal Transplantation
Research Guide
What is Corneal Transplantation?
Corneal transplantation is the surgical replacement of diseased corneal tissue with healthy donor cornea using techniques such as penetrating keratoplasty or lamellar methods including DMEK and DSAEK.
This field encompasses penetrating keratoplasty and lamellar techniques like DMEK/DSAEK, focusing on graft survival, rejection mechanisms, and surgical innovations. Key papers include Dapena et al. (2011) with 373 citations on no-touch DMEK technique and Hos et al. (2019) with 283 citations comparing immune reactions in lamellar versus penetrating transplants. Over 10 listed papers exceed 140 citations each.
Why It Matters
Corneal transplantation restores vision in end-stage corneal diseases like Fuchs endothelial dystrophy, with lamellar techniques reducing rejection rates compared to penetrating keratoplasty (Hos et al., 2019). Innovations like no-touch DMEK improve graft attachment and visual outcomes (Dapena et al., 2011). Cell-based therapies using Rho kinase inhibitors enable endothelial regeneration, addressing donor shortages (Okumura et al., 2016). These advances increase success rates to over 90% in select cases (Tandon et al., 2019).
Key Research Challenges
Graft Rejection Mechanisms
Immune reactions persist in lamellar techniques like DALK, DSAEK, and DMEK despite reduced antigen exposure compared to penetrating keratoplasty. Endothelial alloreactivity drives chronic rejection (Hos et al., 2019). Strategies for donor matching remain suboptimal.
Donor Tissue Preparation
Standardized no-touch harvesting for DALK and DMEK from single corneas risks damage to delicate Descemet membrane. Technique consistency affects graft viability (Groeneveld–van Beek et al., 2012). Scalability for high-volume surgery is limited.
Endothelial Cell Expansion
Culturing human corneal endothelial cells for regenerative therapy faces inconsistent proliferation and phenotype maintenance. TGF-β inhibition enables expansion but requires optimization for clinical use (Okumura et al., 2013). Rho kinase inhibitors show promise but need long-term efficacy data (Okumura et al., 2016).
Essential Papers
Standardized “No-Touch” Technique for Descemet Membrane Endothelial Keratoplasty
Isabel Dapena, Kyros Moutsouris, Konstantinos Droutsas et al. · 2011 · Archives of Ophthalmology · 373 citations
We describe a standardized technique for "no-touch" isolated Descemet membrane transplant, ie, Descemet membrane endothelial keratoplasty (DMEK). All essential steps, including patient preparation ...
Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation
Deniz Hos, Mario Matthaei, Felix Bock et al. · 2019 · Progress in Retinal and Eye Research · 283 citations
In the past decade, novel lamellar keratoplasty techniques such as Deep Anterior Lamellar Keratoplasty (DALK) for anterior keratoplasty and Descemet stripping automated endothelial keratoplasty (DS...
Descemet membrane endothelial keratoplasty (DMEK) for Fuchs endothelial dystrophy: review of the first 50 consecutive cases
L. Ham, Isabel Dapena, Chantal van Luijk et al. · 2009 · Eye · 226 citations
Optimizing Descemet Membrane Endothelial Keratoplasty Using Intraoperative Optical Coherence Tomography
Philipp Steven, Carolin Le Blanc, Kai Velten et al. · 2013 · JAMA Ophthalmology · 190 citations
Intraoperative OCT enhances the visibility of graft orientation and unfolding, thereby improving safety of the DMEK procedure. Overall, iOCT is a helpful device that may support surgeons in all ste...
Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction
Naoki Okumura, Yuji Sakamoto, Keita Fujii et al. · 2016 · Scientific Reports · 178 citations
Abstract The corneal endothelium maintains corneal transparency; consequently, its dysfunction causes severe vision loss. Tissue engineering-based therapy, as an alternative to conventional donor c...
Corneal transplantation in the modern era
Radhika Tandon, Rashmi Singh, Noopur Gupta et al. · 2019 · The Indian Journal of Medical Research · 175 citations
Corneal blindness is one of the major causes of reversible blindness, which can be managed with transplantation of a healthy donor cornea. It is the most successful organ transplantation in the hum...
Inhibition of TGF-β Signaling Enables Human Corneal Endothelial Cell Expansion In Vitro for Use in Regenerative Medicine
Naoki Okumura, EunDuck P. Kay, Makiko Nakahara et al. · 2013 · PLoS ONE · 155 citations
Corneal endothelial dysfunctions occurring in patients with Fuchs' endothelial corneal dystrophy, pseudoexfoliation syndrome, corneal endotheliitis, and surgically induced corneal endothelial damag...
Reading Guide
Foundational Papers
Start with Dapena et al. (2011, 373 citations) for no-touch DMEK technique; Ham et al. (2009, 226 citations) for early outcomes; Peh et al. (2011, 153 citations) for cell cultivation basics.
Recent Advances
Hos et al. (2019, 283 citations) on immune reactions; Tandon et al. (2019, 175 citations) on modern era overview; Okumura et al. (2016, 178 citations) on Rho kinase therapy.
Core Methods
No-touch DMEK graft preparation (Dapena et al., 2011); intraoperative OCT (Steven et al., 2013); TGF-β inhibition and Rho kinase blockers for cell expansion (Okumura et al., 2013; 2016).
How PapersFlow Helps You Research Corneal Transplantation
Discover & Search
Research Agent uses searchPapers and citationGraph to map DMEK evolution from Dapena et al. (2011, 373 citations) to Hos et al. (2019, 283 citations), revealing citation clusters on rejection risks; exaSearch uncovers related donor optimization papers; findSimilarPapers expands from Melles' no-touch technique to global variants.
Analyze & Verify
Analysis Agent applies readPaperContent to extract DMEK surgical steps from Dapena et al. (2011), verifies rejection rate claims in Hos et al. (2019) via verifyResponse (CoVe) against GRADE B evidence, and runs PythonAnalysis on cell expansion data from Okumura et al. (2013) for statistical proliferation trends.
Synthesize & Write
Synthesis Agent detects gaps in intraoperative OCT for DMEK (Steven et al., 2013) versus rejection studies, flags contradictions in immune response data; Writing Agent uses latexEditText, latexSyncCitations for surgical protocol drafts, and latexCompile for illustrated reviews with exportMermaid diagrams of graft unfolding.
Use Cases
"Analyze proliferation rates in Rho kinase inhibitor studies for corneal endothelium."
Research Agent → searchPapers 'Okumura Rho kinase' → Analysis Agent → readPaperContent (Okumura et al., 2016) → runPythonAnalysis (pandas plot of cell counts vs. control) → researcher gets matplotlib graph of 2x expansion verified by CoVe.
"Draft LaTeX review of DMEK vs DSAEK outcomes."
Synthesis Agent → gap detection on Hos et al. (2019) → Writing Agent → latexEditText (add rejection tables) → latexSyncCitations (10 papers) → latexCompile → researcher gets PDF with diagrams via exportMermaid for technique comparison.
"Find code for corneal endothelial cell culture simulations."
Research Agent → paperExtractUrls (Peh et al., 2011) → paperFindGithubRepo → githubRepoInspect → researcher gets Python scripts for hCEC expansion models linked to media optimization protocols.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ DMEK papers via searchPapers → citationGraph → GRADE grading, producing structured report on graft survival trends from Dapena (2011) to Ang (2015). DeepScan applies 7-step analysis with CoVe checkpoints to verify intraoperative OCT benefits (Steven et al., 2013). Theorizer generates hypotheses on combined Rho kinase + TGF-β inhibition from Okumura papers (2013, 2016).
Frequently Asked Questions
What defines corneal transplantation?
Surgical replacement of diseased cornea with donor tissue via penetrating keratoplasty or lamellar techniques like DMEK/DSAEK, targeting endothelial dysfunction in Fuchs dystrophy.
What are key methods in DMEK?
No-touch technique involves descemetorhexis and graft implantation without forceps contact (Dapena et al., 2011); intraoperative OCT optimizes unfolding (Steven et al., 2013).
What are seminal papers?
Dapena et al. (2011, 373 citations) standardized no-touch DMEK; Ham et al. (2009, 226 citations) reviewed first 50 DMEK cases; Hos et al. (2019, 283 citations) compared lamellar rejection.
What open problems exist?
Reducing chronic endothelial rejection in lamellar grafts (Hos et al., 2019); scaling cell therapy with inhibitors for donor-independent transplants (Okumura et al., 2016); standardizing no-touch prep from single corneas (Groeneveld–van Beek et al., 2012).
Research Corneal surgery and disorders with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Corneal Transplantation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Corneal surgery and disorders Research Guide